New book by Larry Connors Click here Improve your trading - See how
BusinessNetWire is part of Stock Profiler.US, LLC's News Division. Stock Profiler welcomes investors to chat LIVE about these stocks and more on their upgraded website with FREE Investor Tools, Live Chats, and much more! Sign up now at www.stockprofiler.us. Companies who want to broadcast their message are encouraged to contact Stock Profiler.US, LLC at (603) 424-4420.
-------------------------------------------
Infinity Medical Group Inc. (PINKSHEETS: IMGR | Quote | Chart | News | PowerRating) closed at $0.12 Wednesday, trading 244,011 shares.
Company News- August 20, 2008: Infinity Medical Group Inc. Launches Two New Websites to Promote Its Dental Implant Clinics
Infinity Medical Group Inc. (PINKSHEETS: IMGR | Quote | Chart | News | PowerRating) is pleased to have announced yesterday that it has launched two new websites to promote its dental implant clinics. The site www.2thimplant.com is meant to promote and educate the general public about dental implants, and www.dentalimplantpartners.com is designed to promote the opportunity of joining and learning more about dental implants for dentists. Two thousand Americans will turn 50 every day (1 every 8 seconds) for the next 20 years. Studies show the number of Americans over 55 will grow by 60% in the next 20 years and their buying power will exceed $2 trillion by 2007. (Business Communications Co., Inc., February 2005).
The company is pleased with the launch of www.2thimplant.com and www.dentalimplantpartners.com. It is meant to not only increase awareness with the general public but also serves to enhance the bottom line of its clinics and provide easier access for both dentists and the patients they serve.
About Infinity Medical Group Inc.: Infinity Medical Group Inc. is a specialty healthcare development company focusing on the building, finance and management of cosmetic medical laser and dental implant clinics offering elective procedures. For more information, please visit www.infinitymedical.com.
About Dental Implants:
Dental implants are designed as permanent replacements for missing teeth. A dental implant is a metal post that is surgically placed into the bone under the gums. The purpose of the placement into the bone is to encourage the integration of the dental implants. The bone actually grows around the dental implant, making the tooth secure. A replacement tooth is attached to the titanium post by means of a final abutment.
About Infinity Medical Group Inc.
Specializing in servicing medical, dental professionals and specialty healthcare industry in the acquisition of facilities, equipment technology, systemization, branding, containment and development.
-------------------------------------------
eHealth, Inc. (NASDAQ: EHTH | Quote | Chart | News | PowerRating) closed at $14.24 Wednesday, trading 162,000 shares.
Company News- August 20, 2008: eHealth, Inc. to Present at Upcoming Investor Conferences
eHealth, Inc. (NASDAQ: EHTH), the leading online source of health insurance for individuals, families and small businesses, announced yesterday that its senior management will deliver presentations at two upcoming investor conferences: -- Thomas Weisel Partners Healthcare Conference, on Wednesday, September 3 at 8:35 a.m. EDT. The conference is being held at the Four Seasons Hotel, Boston, MA.
-- Morgan Stanley Global Healthcare Conference, on Tuesday, September 9 at 4:30 p.m. EDT. The conference is being held at the Grand Hyatt Hotel, New York City, NY.
Interested investors can access the live audio webcast of the presentation at www.ehealthinsurance.com under Investor Relations. Please visit the website at least 15 minutes early to register, download, and install any necessary software. A replay of this event will be available on the company's website shortly after the conclusion of the call and will remain available for 14 days.
About eHealth
eHealth, Inc. (NASDAQ: EHTH | Quote | Chart | News | PowerRating) is the parent company of eHealthInsurance, the nation's leading online source of health insurance for individuals, families and small businesses. Through the company's website, www.ehealthinsurance.com, consumers can get quotes from leading health insurance carriers, compare plans side by side, and apply for and purchase health insurance. eHealthInsurance offers thousands of health plans underwritten by more than 175 of the nation's leading health insurance companies. eHealthInsurance is licensed to sell health insurance in all 50 states and the District of Columbia. eHealthInsurance and eHealth are registered trademarks of eHealthInsurance Services, Inc.
-------------------------------------------
Sinobiomed, Inc. (OTCBB:SOBM) closed at $0.72 Wednesday, trading 554,947 shares.
Company News- August 20, 2008: Sinobiomed Corporate Update
Sinobiomed, Inc. ("Sinobiomed", or "the Company") (OTCBB:SOBM) is pleased to have announced yesterday the following business updates:
Malaria Vaccine
The Company is in late stage discussions with Mahidol University in Bangkok, Thailand, to initiate Phase IIb clinical trials of its recombinant malaria candidate vaccine (PfCP2.9) under Mahidol's supervision. The Company expects to begin trials before the end of Q3.
Recombinant Batroxobin (rBAT)
The Company is currently conducting Phase IIb clinical trials of its anti-bleeding agent, recombinant Batroxobin (rBAT), with multiple test groups totalling 328 patients in seven hospitals in China. Results are expected before year's end. Should the product proceed to Phase III clinical trials, it is expected that international governments and organizations would show significant interest. The Company has already received indications of interest from global pharmaceutical companies for joint development, marketing and production.
Native batroxobin, extracted from pit viper venom, is the world's most prescribed biological anti-bleeding agent. Since rBAT is produced through genetic engineering, it reduces the risk of biological contamination and neurotoxicity that have been associated with native batroxobin.
Skincare and Cosmetics Products
The Company's skincare and cosmetics range, launched in early 2007, is achieving significant success. Shanghai Wanxing Bioscience Cosmetics, 50.33% owned by Sinobiomed, is expected to generate sales of more than US$3 million over the coming twelve months with anticipated gross profit margins greater than 70 percent.
Shanghai Wanxing Bioscience Cosmetics has developed a breakthrough skin rejuvenation product that utilizes rh-aFGF, a patented recombinant therapy developed by Sinobiomed that is highly effective in the treatment of diabetic ulcers and burns, in a proprietary formula. Consumers can now purchase a skincare product with an ingredient that is clinically proven to promote healing, which the Company believes helps support healthy and younger looking skin. The product line, with more than 100 SKU's, is sold exclusively through a home shopping channel under the brand name "Kaiying". This initiative is a natural extension of the Company's ability to commercialize biotechnology and successfully penetrate consumer channels.
Shanghai Wanxing Bioscience Cosmetics is currently in discussions with other home shopping channels in China and other emerging markets such as India and Southeast Asia to carry and promote Kaiying's range of skincare and cosmetic products.
Other developments
The Company is conducting research and development in conjunction with several medical universities and expects to have an additional four new products in the pipeline by years end.
ABOUT SINOBIOMED INC.
Sinobiomed Inc. is a leading Chinese developer of genetically engineered recombinant protein drugs and vaccines. Based in Shanghai, Sinobiomed currently has 10 products approved or in development: three on the market, four in clinical trials and three in research and development. The Company's products respond to a wide range of diseases and conditions, including: malaria, hepatitis, surgical bleeding, cancer, rheumatoid arthritis, diabetic ulcers and burns, and blood cell regeneration.
-------------------------------------------
Somatic Systems, Inc. (PINKSHEETS: SMAS | Quote | Chart | News | PowerRating) closed at $0.0003 Wednesday, trading 607,536,952 shares.
Company News- August 20, 2008: Somatic Systems, Inc. to Begin Share Acquisition and Retirement Program to Increase Price per Share
Somatic Systems, Inc. (PINKSHEETS: SMAS | Quote | Chart | News | PowerRating) announced yesterday that it will begin an aggressive share retirement program within the next month. The company has been meeting with shareholders to acquire large blocks of shares, so that it can cancel them to dramatically decrease the amount of shares outstanding.
The company will announce the acquisitions and retirements of shares as they are pending or have been completed starting over the next few weeks. The company resolved to transact these share cancellations to restructure the company's capital without conducting a reverse split of the stock. While the company's existing share structure and significantly undervalued market capitalization still provide tremendous room for growth in Somatic Systems' share prices, a large number of outstanding shares still tends to discourage buyers and demand for the stock.
"While we believe there is tremendous room for price per share increases within our existing capital structure, we have a strong desire to grow our stock price exponentially, and we know that shareholders are concerned about large numbers of outstanding shares," stated Somatic Systems CEO Steven Aronstein. "We think that removing as much as half our shares will have a strong impact on the demand and price for our stock, and is a great alternative to a reverse split."
About Somatic Systems, Inc.
Somatic Systems is the worldwide center for Clinical Somatics, the ground-breaking drug-free, non-surgical approach to pain relief. This proprietary system uses natural, non-invasive movement techniques -- conducted through one-hour hands-on sessions, therapeutic exercises classes, and home exercises lasting as little as 5 minutes a day -- to relieve pain and limitation resulting from accident, trauma and repetitive stress, including back pain, knee pain, joint problems, carpal tunnel syndrome, TMJ, scoliosis, bursitis, sciatica, headaches, tendonitis and more. Clinical Somatics also provides performance gains and injury prevention for casual and professional athletes.
Somatic Systems is pursuing a 3-part growth strategy, consisting of a nationwide rollout of pain management Somatics Clinics; increased production and distribution of therapeutic videos, books, and other retail self-help Somatics Products; and expanded Somatics Training Programs to supply Clinic practitioners serving medical and orthopedic professionals and institutional and corporate programs. The company operates a suite of web sites offering Somatics information, products, resources, and opportunities, at www.somatics.org.
-------------------------------------------
The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BusinessNetWire.US is a division of Stock Profiler.US, LLC's News Division, which includes but is not limited to www.stockprofiler.us, www.associatesfortune.com, www.financialbusinessnews.us, www.fastmoneytalk.com, www.markettelegraph.com, www.thewallstreetleader.com and www.daytradersdigest.com. Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.
Please consult a broker before purchasing or selling any securities mentioned herein. To view full disclaimers and terms of use, go to www.stockprofiler.us.
Keywords: Small Cap Investments, Investor Relations, I/R Services, Investment Tools, Stock Profiles, Stock Market Quotes News, Media Coverage
CONTACT: Businessnetwire.us Tel: +1 603 424 4420 e-mail: info@stockprofiler.us WWW: http://www.businessnetwire.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403
© Copyright 2009 The Connors Group, Inc.
